Alan Nurden: From Early Discoveries to New Therapeutic Advances in von Willebrand Disease
Alan Nurden, Emeritus Research Director at CNRS, Co-Founder of the French National Reference Centre for Inherited Platelet Disorders (CRPP), shared a post on LinkedIn about a recent article by Caterina Casari et al, published in Haematologica:
“This is an excellent review of von Willebrand disease and its therapeutic landscape by three respected experts. It begins with the history of early discoveries and ends with an assessment of the range of new therapeutic advances that offer much hope for a sustainable prophylaxis that will greatly enhance the quality of life of patients.
For me, it is good to see highlighted such pioneers as Judith Poole (Stanford Univ, USA), Theodore Zimmerman (Scripps Clinic, USA), Birger and Margareta Blomback (Karolinska Institute, Sweden), Pïer Mannuccio Mannucci (Milan, Italy) happily still active, and the sadly missed J Evan Saddler (St. Louis, USA); and which extends through to a new generation such as Cécile Denis and Peter Lenting from France to name but two.
This review is highly recommended.”
Title: Historical, current and future treatments for von Willebrand disease
Authors: Caterina Casari, Frank W.G. Leebeek, Flora Peyvandi
Read the Full Article on Haematologica.

Other articles featuring Alan Nurden on Hemostasis Today.
-
Aug 24, 2026, 18:13Chokri Ben Lamine: Ruxolitinib – Comprehensive Clinical Reference
-
Aug 24, 2026, 18:10Yazan Abou-Ismail: ClotCast Episode 8 – What Are Platelets?
-
Aug 24, 2026, 17:11Kristin Neves: Which Hematologic Parameters Guide Your PV Treatment Decisions?
-
Aug 24, 2026, 17:00Should Hormone Therapy Automatically Stop After a Thrombosis? – Thrombosis Canada
-
Aug 24, 2026, 16:52Davide Capodanno: 10 Trials to Watch at the ESC Hot Lines
-
Aug 24, 2026, 16:48Mohd Ashhad: The Science Behind a Safe Transfusion
-
Aug 24, 2026, 16:38PCSK9i Is a Powerful Lipid-Lowering Strategy – But Is It Also Anti-Inflammatory?- JACC Journals
-
Aug 24, 2026, 16:36Alejandro González Veliz։ Does ACC/AHA Lesion Complexity Still Matter?
-
Aug 24, 2026, 16:21Kamlesh Darji: Paraneoplastic Syndromes – Tumor with or without Mediator